
MetaVia Inc.
MTVANasdaqCIK 1638287HealthcareFiscal year ends Dec 31
Reports and events: 278 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-11-1313:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638287-17-000023 |
| 2017-11-1309:04 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001558370-17-008803 |
| 2017-09-2509:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001638287-17-000019 |
| 2017-09-1916:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001638287-17-000017 |
| 2017-08-1409:15 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001558370-17-006610 |
| 2017-08-1408:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638287-17-000011 |
| 2017-08-0707:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001638287-17-000007 |
| 2017-07-2508:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638287-17-000005 |
| 2017-06-2816:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-17-004980 |
| 2017-05-3016:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-036173 |
| 2017-05-2416:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-17-034863 |
| 2017-05-1016:31 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001558370-17-004134 |
| 2017-05-0906:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-17-003876 |
| 2017-04-1317:01 ET | S-1 | Registration statement | 0001104659-17-023417 |
| 2017-04-0616:09 ET | DEF 14A | Proxy statementPeriod 2017-05-23 | 0001047469-17-002384 |
| 2017-03-2121:49 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001558370-17-001962 |
| 2017-03-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-016633 |
| 2017-03-1317:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-17-016147 |
| 2017-03-1009:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-015689 |
| 2017-02-0706:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-006781 |
| 2016-11-0209:24 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001558370-16-009022 |
| 2016-11-0207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-153912 |
| 2016-10-0316:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-148243 |
| 2016-09-1409:14 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001558370-16-008353 |
| 2016-08-1016:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-16-138639 |
| 2016-08-0407:48 ET | S-1/A | Registration statement, amended | 0001047469-16-014663 |
| 2016-06-1306:02 ET | S-1/A | Registration statement, amended | 0001047469-16-013774 |
| 2016-04-1817:16 ET | S-1 | Registration statement | 0001047469-16-012305 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:33 ET. Listed shows no prices and gives no investment advice.